QA: OMEROS CORP in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001285819_2021_OMEROS_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001285819, OMEROS CORP

  xvar xval
0 AssetsCurrent 151,285,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 29,757,000
4 LiabilitiesCurrent 36,736,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 902,000
8 SellingGeneralAndAdministrativeExpense 72,695,000
9 ResearchAndDevelopmentExpense 110,817,000
10 remainder_Expenses 14,740,000
11 remainder_Revenues 73,813,000
12 remainder_NetIncome -12,720,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 181,042,000
1 Liabilities 36,736,000
2 Expenses 199,154,000
3 Revenues 73,813,000
4 StockholdersEquity 144,306,000
5 NetIncome -138,061,000
6 ComprehensiveNetIncome -138,061,000
7 BaseVar 251,732,500
8 EconomicCapitalRatio 1.01

Edgar->Model Mapping

Feature Distribution

Change over Time